Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP477918.RAQlbf3ECvDNmTdtDv7rpdC_kS-dtWh64P65WgkBhcRko130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477918.RAQlbf3ECvDNmTdtDv7rpdC_kS-dtWh64P65WgkBhcRko130_provenance.
• NP206124.RA8IhSVnBd-bZLutlsRcXyDLvZDJc6v0YVt6yaO8LAbuo130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206124.RA8IhSVnBd-bZLutlsRcXyDLvZDJc6v0YVt6yaO8LAbuo130_provenance.
• NP542918.RAjbPS6Bj9UfoMnc1ZGDYkE2JlRAyJiHn_lTiL8tGgMvQ130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542918.RAjbPS6Bj9UfoMnc1ZGDYkE2JlRAyJiHn_lTiL8tGgMvQ130_provenance.
• NP360236.RARmKAwJZ-vnAQZWohVp-zbqRa7O8qsnK3rVq5X1gvy2w130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360236.RARmKAwJZ-vnAQZWohVp-zbqRa7O8qsnK3rVq5X1gvy2w130_provenance.
• NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498497.RAmUF3uXtxX3Fyq2rGuYyMcVn-wNRjH3aVgzsDnWrv_V0130_provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP373902.RAHt1HzcWskw_ddUcrahLXbQmwtf4xjzQExRzuqSmSVQw130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373902.RAHt1HzcWskw_ddUcrahLXbQmwtf4xjzQExRzuqSmSVQw130_provenance.
• NP893908.RA2kQZowDin4YQzn6rMNQE1aZiONNz8WMcJGZpTQr0yzk130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893908.RA2kQZowDin4YQzn6rMNQE1aZiONNz8WMcJGZpTQr0yzk130_provenance.
• NP307656.RASL0zyzZdoLpjYJ_y7mtxzZ9DxpBrHKifLDAZRk4gFEk130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307656.RASL0zyzZdoLpjYJ_y7mtxzZ9DxpBrHKifLDAZRk4gFEk130_provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP707868.RAO0UXisug6p5iO7314ZdYzvGOkhrlVEAWVRrBTdFhSaw130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707868.RAO0UXisug6p5iO7314ZdYzvGOkhrlVEAWVRrBTdFhSaw130_provenance.
• NP306993.RAs6cvPHxpfA4mE8I6ieJDQH3ViFH3HfW_MTgdY2VfO0A130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306993.RAs6cvPHxpfA4mE8I6ieJDQH3ViFH3HfW_MTgdY2VfO0A130_provenance.
• NP666097.RAoBUU5bL-g6bxOHcCT_eTzwhiB4D2U7VGpt0W8uteHP4130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666097.RAoBUU5bL-g6bxOHcCT_eTzwhiB4D2U7VGpt0W8uteHP4130_provenance.
• NP1379271.RAg-me76x3iZLr86D2j1nL6imcxzsK0RiHctoOzdUV7Qg130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379271.RAg-me76x3iZLr86D2j1nL6imcxzsK0RiHctoOzdUV7Qg130_provenance.
• NP1379273.RAiFG3EJfpcD-K8X-hNw75AoIj-IHBiGvaxGChR21Dfw4130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379273.RAiFG3EJfpcD-K8X-hNw75AoIj-IHBiGvaxGChR21Dfw4130_provenance.
• NP1379274.RAiUGkusc4Xu3I0YbzMeDXYBW8japLUIRkpfa5xb-KDUw130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379274.RAiUGkusc4Xu3I0YbzMeDXYBW8japLUIRkpfa5xb-KDUw130_provenance.
• NP1379275.RAgKMi4C36_omrqC-5wwQO4aVwZoTkWxnjfchWIK7n4Bw130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379275.RAgKMi4C36_omrqC-5wwQO4aVwZoTkWxnjfchWIK7n4Bw130_provenance.
• NP1379277.RAp7_sXhoPg6r-Eu_A_IOFwZfzeguZenCOspAnVKOPuUQ130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379277.RAp7_sXhoPg6r-Eu_A_IOFwZfzeguZenCOspAnVKOPuUQ130_provenance.
• NP666036.RAGcK6U6-EuF07G-Mi3WOru7p9H8lAJ5k9SjEk9ARiLBM130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666036.RAGcK6U6-EuF07G-Mi3WOru7p9H8lAJ5k9SjEk9ARiLBM130_provenance.
• NP666051.RAHYB-RwthiLJvmyAVZrHE8HGjFFDbFlc-kfmxDdoEt0c130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666051.RAHYB-RwthiLJvmyAVZrHE8HGjFFDbFlc-kfmxDdoEt0c130_provenance.
• NP666063.RAMMdjKnhfh5JxlJ1J45USg0w22_C9ThknPkkiYM-GO1w130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666063.RAMMdjKnhfh5JxlJ1J45USg0w22_C9ThknPkkiYM-GO1w130_provenance.
• NP307166.RA_z_n6gNmk0clm8lTobCEufMWCKU_fhIETvzXuCr_M9Y130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307166.RA_z_n6gNmk0clm8lTobCEufMWCKU_fhIETvzXuCr_M9Y130_provenance.
• NP306991.RALRjjWA8uUknX37Y4pBTsus2Gcwe4NAgkgv_Y6RrPwAo130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306991.RALRjjWA8uUknX37Y4pBTsus2Gcwe4NAgkgv_Y6RrPwAo130_provenance.
• NP666040.RA2yk7iiRr9hA_Q-Q0l03tWl1pF6PAJs3CiKSDEYZwFyg130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666040.RA2yk7iiRr9hA_Q-Q0l03tWl1pF6PAJs3CiKSDEYZwFyg130_provenance.
• NP1379270.RAwoD8D9ja6SCkYw0QbmyYfiuuesk5cQP5YFhJXK06fPU130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379270.RAwoD8D9ja6SCkYw0QbmyYfiuuesk5cQP5YFhJXK06fPU130_provenance.
• NP1379272.RAyvPKME4xcmY1sdF77XZ2fE4WCcP6cgoZSPuq_WTTv0E130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379272.RAyvPKME4xcmY1sdF77XZ2fE4WCcP6cgoZSPuq_WTTv0E130_provenance.
• NP1379276.RA2PZIt7zpvnLjNdUBWPQGcQy0XgBqCaZN8C6VIlGamIc130_assertion description "[Interestingly, the p15INK4B gene was frequently methylated in patients with high-risk MDS (refractory anemia with excess blasts [RAEB], RAEB in transformation [RAEB-t], and overt leukemia evolved from MDS; 14/18 [78%]) compared with patients with low-risk MDS (refractory anemia [RA] and refractory anemia with ring sideroblast [RARS]; 1/12 [8%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1379276.RA2PZIt7zpvnLjNdUBWPQGcQy0XgBqCaZN8C6VIlGamIc130_provenance.